Insulin Therapy in Critical Illness

Canadian Journal of Diabetes

Volumn 28, Issue 1, 2004, Pages 43-49

  Van Den Berghe, Greet ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Blood glucose; Critical illness polyneuropathy; Glycemic control; Insulin; Intensive care unit; Intensive insulin therapy; Morbidity; Mortality

Indexed keywords

GLUCOSE; INSULIN;

ADAPTATION; ALGORITHM; ASSISTED VENTILATION; CLINICAL TRIAL; CRITICAL ILLNESS; DRUG INDICATION; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; METABOLIC REGULATION; MORTALITY; PATHOPHYSIOLOGY; REVIEW; RISK REDUCTION;

EID: 1642325620     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Takala J, Ruokonen E, Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 1999;341:785-792.
2. Vincent J-L. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Crit Care. 2001; 5(suppl 2):S1-S5.
3. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med. 1993;328:1471-1478.
4. Zochodne DW, Bolton CF, Wells GA, et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 1987;110:819-841.
5. Leijten FS, de Weerd AW. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg. 1994;96:10-19.
6. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med. 1996; 24:1408-1416.
7. Venn R. Paper reports overview: sepsis, insulin and noninvasive ventilation [commentary]. Crit Care. 2002;6:93-94.
8. Hawryluck L, Crippen D. Ethics and critical care in the new millennium [editorial]. Crit Care. 2002;6:1-2.
9. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001; 15:533-551.
10. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol. 2001;58:1209-1212.
11. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
12. Johan Groeneveld AB, Beishuizen A, Visser FC. Insulin: a wonder drug in the critically ill? Crit Care. 2002;6:102-105.
13. Malmberg K, Norhammar A, Ryden L. Insulin treatment post myocardial infarction: the DIGAMI study. Adv Exp Med Biol. 2001;498:279-284.
14. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51:540-544.
15. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery. 2000;128:757-760.
16. Díaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction. The ECLA Glucose-insulin-potassium pilot trial. Circulation. 1998;98:2227-2234.
17. Jonassen AK, Sack MN, Mjos OD, et al. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res. 2001;89:1191-1198.
18. Intensive insulin therapy in critically ill patients [letter]. N Engl J Med. 2002;346:1586-1588.
19. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003;31:359-366.
20. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
21. Das UN. Insulin and the critically ill [letter]. Crit Care. 2002;6:262-263.
22. Wall RJ, Dittus RS, Ely EW. Protocol-driven care in the intensive care unit: a tool for quality [commentary]. Crit Care. 2001;5:283-285.